Problem statement: Answer the MCQ question.
Query: Which drug has a -3.105% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) Cn1c(SCC(=O)N2CCCCC2)nc2c([nH]c3ccccc32)c1=O
b.) CCC(=O)N=C1SC2CS(=O)(=O)CC2N1c1cccc(OC)c1
c.) COc1ccc(C(CNC(=O)c2ccc(S(=O)(=O)N3CCCC3)cc2)N2CCOCC2)cc1
Answer: b. CCC(=O)N=C1SC2CS(=O)(=O)CC2N1c1cccc(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)N=C1SC2CS(=O)(=O)CC2N1c1cccc(OC)c1
CCC(=O)N=C1SC2CS(=O)(=O)CC2N1c1cccc(OC)c1
N-[3-(3-methoxyphenyl)-5,5-dioxo-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]thiazol-2-ylidene]propanamide